Comprehensive molecular characterization of urothelial bladder carcinoma
Roeland Verhaak(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Bradley M. Broom, Bo Peng(Southern University of Science and Technology), John N. Weinstein(The University of Texas MD Anderson Cancer Center), Nianxiang Zhang(The University of Texas MD Anderson Cancer Center), C. Smith(Vanderbilt University), Seth P. Lerner(Baylor College of Medicine), Chad J. Creighton(Baylor College of Medicine), David J. McConkey(Johns Hopkins University), Philip L. Lorenzi(City Of Hope National Medical Center), Jiexin Zhang(The University of Texas MD Anderson Cancer Center), Xiaoping Su(Guangxi Medical University), Michael T. Ryan(Australian Regenerative Medicine Institute), Patricia Garrido Castro(Baylor College of Medicine), Richard C. Gibbs(Broad Institute), Thomas Motter(The University of Texas MD Anderson Cancer Center), Wenyi Wang(The University of Texas MD Anderson Cancer Center), Wenbin Liu(Guangzhou University), Zhenlin Ju(The University of Texas MD Anderson Cancer Center), Hui Yao(The University of Texas MD Anderson Cancer Center), Weiguo Jian(University of Southern California), Margaret Morgan(Broad Institute), Whitney D. McClenden(Broad Institute), Lawrence A. Donehower(Baylor College of Medicine), Rehan Akbani
Cited by 3,058
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k